CHAPTERS
- 0:00 – 1:47
RFK Jr. at HHS and the "roaches" of corporate capture
Joe and Brigham open by framing the moment as a power shift: RFK Jr. taking charge at HHS and forcing long-protected interests into the open. Brigham sets the tone by describing how deep regulatory capture runs across health-related agencies.
- 1:47 – 5:22
Vaccine policy flashpoint: CDC resignation and Hep B shots for babies
The conversation quickly moves to a recent CDC resignation and debates around infant vaccination policy. They argue incentives and mandates often follow revenue, not risk-based logic.
- 5:22 – 6:49
Inside the FDA meeting: "They’ll smile… and screw you"
Brigham recounts a Kennedy-arranged meeting with FDA staff that seemed cordial—until an insider warned him the agency would ignore the concerns. This kicks off a detailed critique of how FDA decisions are shaped by industry narratives and funding.
- 6:49 – 10:39
GLP-1s, compounding, and dosing incentives: why side effects spike
They zoom into GLP-1 drugs (Ozempic/Wegovy equivalents) as the test case for capture: patents, access, and reimbursement. Brigham argues many harms come from dose escalation driven by formularies rather than patient-specific optimization.
- 10:39 – 20:46
Manufacturing hypocrisy and the "backorder list" data fight
Brigham challenges the pharma narrative that compounded products are unsafe by pointing to FDA warning letters against major manufacturers and alleged inspection gaps. He also describes a large-scale pharmacy availability audit used to dispute the FDA’s claim that shortages were resolved.
- 20:46 – 28:50
The bigger play: reclassifying drugs as biologics to lock out competition
Brigham alleges pharma is attempting to reclassify widely used therapies as biologics to extend monopoly protection and eliminate compounding entirely. This becomes his central warning about how pricing reform can be sidestepped via regulatory definitions.
- 28:50 – 47:22
Court documents, legacy staff, and RFK’s "Whac-A-Mole" enforcement problem
They describe hidden policy changes via court filings and internal resistance from long-tenured employees. Brigham claims RFK intervened after being alerted, forcing emergency calls and issuing mandates to keep peptide access open through compliant channels.
- 47:22 – 49:53
Captured science and psychiatry: SSRIs, screening tools, and placebo-level benefits
The discussion pivots to mental health, arguing diagnostic tools and drug narratives were built to expand prescribing, not clarify biology. Brigham and Rogan claim SSRIs barely outperform placebo while lifestyle interventions show stronger effects.
- 49:53 – 1:01:06
ADHD questionnaires in real time, childhood labels, and lifestyle as medicine
Rogan takes an ADHD self-report scale live, illustrating how context changes answers—and how easily meds can be justified. Brigham shares his own childhood experience being mislabeled and argues movement, training, and purpose can be protective.
- 1:01:06 – 1:18:10
Texas MAHA bills: lobbying warfare over food stamps, school lunches, and labels
Brigham describes state-level legislative battles to reduce ultra-processed food harms—met by intense lobbying from major corporations and health NGOs. They detail the political tactics used to reframe health reforms as discriminatory or harmful to communities.
- 1:18:10 – 1:50:48
Glyphosate, Monsanto, and the push for legal immunity from future lawsuits
The focus turns to agricultural chemicals, arguing regulators and lawmakers are being pressured to shield manufacturers from liability. They connect U.S. exposure levels, differences with Europe, and claims about end-of-harvest spraying practices.
- 1:50:48 – 1:56:37
Personal outcomes and regenerative toolkits: dementia, obesity, bloodwork, and vision
They share anecdotes of patient improvement using a stack of interventions—hyperbaric therapy, peptides, stem cells, red light, and personalized supplementation. The segment frames “preventative and personalized” care as the alternative to insurance-driven sick care.
- 1:56:37 – 3:11:43
From UFOs to AI: engineered humans, surveillance states, and the next species transition
The conversation broadens into speculation: UAP materials, interdimensional theories, biotech, and AI convergence. They discuss surveillance tools, deepfakes, CRISPR gene editing, neural interfaces, and the fear that humanity is being pushed toward integration with machines.
- 3:11:43 – 3:20:07
Peru tridactyl mummies, ancient architecture, and the "what if it’s real" conclusion
They close by revisiting Jesse Michels’ coverage of Peru’s tridactyl mummies and related anomalies, arguing it challenges the reflexive “hoax” dismissal. The episode ends with a mix of wonder, uncertainty, and a final wrap-up and plug.
